ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
Antibiotic-loaded synthetic calcium sulfate (Stimulan) in the surgical management of fracture-related complications in a low-middle income country.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe use of calcium sulfate antibiotic delivery systems are underreported in low- and middle-income countries (LMICs), despite the high burden of fracture-related infections and complications. This study evaluates the use of Stimulan in fracture-related complications in a resource-limited setting.
methodsA prospective analysis was conducted of all patients treated with Stimulan (Biocomposites Ltd., Keele, UK) for fracture-related complications, between July-September 2023 at Children's Surgical Centre, Cambodia. Patients were followed up regularly at six, nine, and 12 months post-operatively and assessed on the following outcomes: radiological union, radiological/clinical infection remission and functional outcome.
resultsFive out of six patients (83.3%) treated for FRI were clinically and radiologically infection-free, and six out of eight patients (75%) achieved fracture union, at 12 months follow-up. Surgical wounds had healed with no evidence of infection in seven (87.5%) patients. Five non-unions (71.4%) had radiologically healed by 12 months. All patients were fully weightbearing at one year, with two (25%) still requiring walking aids.
conclusionThe use of Stimulan in LMICs appears to provide an effective adjunct for managing fracture-related complications, however more research is required to investigate its efficacy in the treatment of infected non-unions in a LMIC setting.
Indexed as
Identifiers
42862389What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.